Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Country: Сингапур

Језик: Енглески

Извор: HSA (Health Sciences Authority)

Доступно од:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Класа:

Class D medical device

Произведен од:

Bio-Technology General (Israel) Ltd.

Терапеутска област:

Orthopaedics

Терапеутске индикације:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Резиме производа:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Датум одобрења:

2017-04-28